Related Experiment Video
Updated: Jan 25, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on
Felix S Wicke1, Martin A Schaller2, Kateryna Karymova3
1Institute of General Practice, Goethe-University, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany. wicke@allgemeinmedizin.uni-frankfurt.de.
Insights
Stroke risk in atrial fibrillation (AF) patients is assessed using the CHA₂DS₂-VASc score. This study found lower ischemic stroke rates in a German AF population compared to international data, suggesting potential regional differences in risk stratification.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Oral anticoagulants are crucial for preventing ischemic stroke in atrial fibrillation (AF) patients.
- Accurate stroke risk assessment is essential before initiating oral anticoagulants.
- The CHA₂DS₂-VASc score is the current guideline-recommended tool for stroke risk assessment in AF.
Purpose of the Study:
- To estimate ischemic stroke risk stratified by the CHA₂DS₂-VASc score in a representative German AF population.
- To compare these estimated risks with findings from previous international studies.
- To evaluate the applicability of the CHA₂DS₂-VASc score in a specific geographic region.
Main Methods:
- Retrospective cohort study utilizing secondary data from patients with atrial fibrillation.
- CHA₂DS₂-VASc scores were calculated based on 2014 diagnoses.
- Outcomes (ischemic stroke, thromboembolic events) were assessed during 2015-2016.
Main Results:
- The incidence rate of ischemic stroke was 2.2 per 100 person-years (961/30,299 patients).
- The incidence rate of any thromboembolic event was 3.6 per 100 person-years (1553/30,299 patients).
- Ischemic stroke rates stratified by CHA₂DS₂-VASc score were generally lower than previously reported international data.
Conclusions:
- The CHA₂DS₂-VASc score's performance in the German population differs from international findings, showing a trend towards lower ischemic stroke risk.
- These results highlight potential regional variations in stroke risk among AF patients.
- Further refinement of stroke risk estimation tools for atrial fibrillation patients is warranted.
Background:
Oral anticoagulants can cause potentially serious adverse events. Therefore, before prescribing oral anticoagulants for ischemic stroke prevention in patients with atrial fibrillation (AF), stroke risk assessment is required to identify patients that are likely to benefit from treatment. Current guidelines recommend the CHA2DS2-VASc-score for stroke risk assessment. The CHA2DS2-VASc-score is based on observational studies from different treatment settings and countries. As ischemic stroke risk differs by setting and region, the aim of this study is to estimate ischemic stroke risk (stratified by the CHA2DS2-VASc-score) for a broadly representative population with AF from southern Germany and compare them to results from previous studies.
Methods:
The study design is a retrospective cohort study on patients with atrial fibrillation based on secondary data. We calculated CHA2DS2-VASc-score based on patient's diagnoses recorded in the year 2014 and assessed outcomes in 2015-2016. The primary outcome is hospitalization for ischemic stroke. The secondary outome is hospitalizations for any thromboembolic event, including ischemic stroke, transient ischemic attack, peripheral arterial embolism, pulmonary embolism, and mesenterial embolism. We estimated the incidence rates of the outcomes (and corresponding 95%-confidence intervals) stratified by CHA2DS2-VASc-score.
Results:
The primary endpoint occurred in 961 of the 30,299 patients constituting the study population, resulting in a total incidence rate of 2.2 per 100 person-years. The secondary endpoint occurred in 1553 patients (3.6 per 100 person-years). Ischemic stroke rates stratified by the CHA2DS2-VASc-score tended to be lower than those reported previously. Thromboembolic event rates stratified tended to be similar to those reported previously.
Conclusions:
Our results show that the performance of the CHA2DS2-VASc-score differs in the German population, as compared to internationally published data, with an overall trend towards lower risk of ischemic stroke in uncoagulated patients with AF. These results should not be practice changing, but they emphasize that stroke risk estimation in patients with atrial fibrillation should be further refined.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Data Collection by Observations
An astronomer viewing the motion and brightness of stars in the sky and recording the data is an example of observational data collection. A botanist recording...
Observational Studies
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
Data Reporting and Recording
Secondary Active Transport
Secondary Healthcare System

